BOBULSKY SUSAN (SVP, Diagnostics, clonoSEQ) sold 0.3% of their position (1.20K shares) of ADAPTIVE BIOTECHNOLOGIES CORP on the open market
Open‑market sale worth $32.3K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 9/17/2026ACC: 0001820885-26-000023
Officer· SVP, Diagnostics, clonoSEQ
Since Aug 2020
-1.20K
Net shares
Net seller
$32.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
1.20K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−1.20K
Price / share
$27.00
Trade value
$32.27K
% of position
0.3%
9/15/2026
396.99K→395.79K
Total
Net shares
−1.20K
Net value
-$32.27K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 9/15/2026 | S · Sale | −1.20K | $27.00 | $32.27K | 0.3% | 396.99K | 395.79K |
| Total | −1.20K | -$32.27K | ||||||
Derivative Transactions0
No derivative transactions reported